Find & Apply For Quality Control Analyst Jobs In Durham, North Carolina
Quality Control Analyst jobs in Durham, North Carolina involve analyzing and evaluating products to ensure they meet quality standards. Responsibilities include conducting tests, documenting findings, and recommending improvements. These positions require attention to detail, strong analytical skills, and the ability to work independently. Below you can find different Quality Control Analyst positions in Durham, North Carolina.
Jobs in Durham
Browse jobs from a variety of sources below, sorted with the most recently published, nearest to the top. Click the title to view more information and apply online.
Sr. Spclst, Quality Systems & Compliance
Merck & Co.
Durham, NC
Specialist, Quality Control, Microbiology
Unclassified
Durham, NC
QC Environmental Monitoring (EM) Analyst 1 – 2nd Shift
Biomerieux
Durham, NC
Deviation Management Specialist
Piper Companies
Durham, NC
Specialist, Quality Control-1
Merck & Co.
Durham, NC
Specialist, Quality Control-1
Merck & Co.
Durham, NC
Latest Jobs in Durham
Salary Information & Job Trends In this Region
Quality Control Analysts in Durham, North Carolina are integral to ensuring product integrity and compliance with standards. - Entry-level Quality Control Analyst salaries range from $40,000 to $55,000 per year - Mid-career Quality Assurance Specialist salaries range from $55,000 to $70,000 per year - Senior Quality Manager salaries range from $70,000 to $90,000 per year The role of Quality Control Analysts in Durham has a rich history, initially linked to the tobacco and textile industries which required stringent quality checks to maintain product standards. Over the years, the profession has evolved from basic inspections to include sophisticated analytical responsibilities and the use of advanced statistical methods to ensure the highest quality of products in biotechnology, pharmaceuticals, and manufacturing sectors. Current trends for Quality Control Analysts in Durham include the adoption of automation technologies, increased regulatory scrutiny particularly in the biopharmaceutical sector, and a growing emphasis on sustainable and ethical production practices.
